Peer to Peer Pharma speaking programs in cancer immunotherapy Keytruda, Opdivo, Tecentriq KOLs in California & Arizona

July 31, 2020

By: Stephen

How does a Pharma sales rep begin to understand cancer immunotherapy?

To begin, let’s look at what cancer immunotherapy does. Cancer immunotherapy is a form of cancer treatment that uses the power of a human body’s own immune system to control, prevent, and eliminate cancer.

Most if not all pharmaceutical companies that produce immunotherapy products are looking to expand their industry footprint. Each company looks to their Pharma sales reps and marketing teams to bring new valuable information, contacts, and leads to help build their pre-call planning pharmaceutical sales strategies.

Where do you start when building a pre-call plan on such a large topic like cancer immunotherapy? You could target different types of immunotherapy including checkpoint inhibitors, t-cell therapy, cancer vaccines, or oncolytic virus therapy. This will help narrow down your options but still leaves you with a massive segment of the pharmaceutical industry.

One good idea is to look into the RX products within each pharmaceutical industry to improve your pharmaceutical speaker programs. But once you have found the RX products in your specific cancer immunotherapy sector, how do you match those RX products to Healthcare Professionals (HCP) and Key Opinion Leaders (KOL)?

That's where SpeakerBook can help. SpeakerBook can take those targeted cancer immunotherapy RX products and attach them to KOLs and HCPs to help any sales rep improve their pre-call planning pharmaceutical sales. SpeakerBook has created a new way of searching for KOLs and HCPs. Sales reps can now just search for the product they would like more information on to receive active KOLs that are engaging with that product. It's that simple.

SpeakerBook helps you find KOLs that have engaged with the RX products that matter to you and your Pharma organization sales goals.

Now that we know how SpeakerBook works, how can we use the application to help us develop a pre-call Pharma plan for cancer immunotherapy? A quick Google search of cancer immunotherapy drugs shows That's where Keytruda, Opdivo, and Tecentriq as being popular solutions to work with your immune system to fight cancer. Now that we have identified some of the most active cancer immunotherapy drugs, we can use SpeakerBook to search the regions that matter to our pharmaceutical organizations specific sales goals.

EXAMPLE: In this example I’m a sales rep in Southern California looking to better understand my current market. Not only am I looking to maintain and grow my current sales region, I’m also looking to expand into other Pharma sales territories. Specifically parts of Southern Arizona.

We could build a large list for every HCP and KOL in the USA but in this example we are looking to build a target list of KOLs in just Southern California and Arizona.

A quick SpeakerBook KOL speaker search for the product Keytruda, Opdivo, and Tecentriq in the states of California and Arizona shows 72 KOLs and HCP speakers for the top cancer immunotherapy products in the regions and territories that matter to you.

SpeakerBook John R Pawloski KOL
SpeakerBook John R Pawloski KOL

Klaus W Wagner of the VA San Diego Healthcare System has the most KOL engagements and Pharma speaking programs with the company Merck. Klaus W Wagner’s total is $52,500 in speaking engagement fees for the product Keytruda from Merck. Keytruda makes up 79.4% of Klaus W Wagner’s total pharmaceutical industry payments. The product Abraxane from Celgene makes up the remaining 20.6% of Klaus industry payments making him an exclusive KOL speaker for the products Keytruda and Abraxane. In 2018 Klaus spoke exclusively for Keytruda from August through December totaling 9 speaking programs.

Top 5 active Pharma speaking programs in cancer immunotherapy for Keytruda, Opdivo, and Tecentriq in California and Arizona

Image KOL Speaking Fee RX Product
SpeakerBook Klaus W. Wagner Key Opinion Leaders Klaus W. Wagner $52,500 Keytruda
SpeakerBook Misagh Karimi Key Opinion Leaders Misagh Karimi $46,500 Tecentriq
SpeakerBook Kasra Karamlou Key Opinion Leaders Kasra Karamlou $45,715 Opdivo
SpeakerBook Steven J Oday Key Opinion Leaders Steven J Oday $42,545 Opdivo
SpeakerBook Sujith Rao Kalmadi Key Opinion Leaders Sujith Rao Kalmadi $31,720 Tecentriq

Each SpeakerBook profile gives an overview of all of the speaker’s pharmaceutical engagements with every pharmaceutical company in the industry. SpeakerBook uses the 2018 open payments Sunshine Act data to catalogue and discover the most active and engaging KOLs and HCPs in the pharmaceutical industry.

Use SpeakerBook to research almost any cancer immunotherapy RX product to find Key Opinion Leaders and Healthcare Professionals in your local territories.

Download and try SpeakerBook in the iOS app store today.